This is a Validated Antibody Database (VAD) review about human HBA2, based on 193 published articles (read how Labome selects the articles), using HBA2 antibody in all methods. It is aimed to help Labome visitors find the most suited HBA2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HBA2 synonym: ECYT7; HBA-T2; HBH

Abcam
domestic rabbit monoclonal (EPR3608)
  • immunohistochemistry - paraffin section; mouse; 1:250; fig 5f
Abcam HBA2 antibody (Abcam, ab92492) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 5f). J Am Heart Assoc (2022) ncbi
mouse monoclonal (7E1F)
  • western blot; human
Abcam HBA2 antibody (Abcam, ab77125) was used in western blot on human samples . Theranostics (2021) ncbi
domestic rabbit monoclonal (EPR3608)
  • immunocytochemistry; human; loading ...; fig 7a
  • western blot; human; loading ...; fig 7c
Abcam HBA2 antibody (Abcam, ab92492) was used in immunocytochemistry on human samples (fig 7a) and in western blot on human samples (fig 7c). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (EPR3608)
  • western blot; mouse; fig 8
In order to analyze ischemia-induced brain damage due to semaphorin3A increasing vascular permeability, Abcam HBA2 antibody (abcam, Ab92492) was used in western blot on mouse samples (fig 8). Sci Rep (2015) ncbi
Bio-Rad
human monoclonal (AbD05988)
  • western blot; human; 1:100
Bio-Rad HBA2 antibody (Serotec, HCA042) was used in western blot on human samples at 1:100. Int J Oncol (2014) ncbi
Dako
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:1000; fig s2c
Dako HBA2 antibody (Agilent DAKO, M082329-2) was used in immunohistochemistry on human samples at 1:1000 (fig s2c). Cell Rep (2022) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4b
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4b). Nat Cancer (2022) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4b2
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry - paraffin section on human samples (fig 4b2). PLoS Pathog (2022) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; loading ...; fig 1d
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry on human samples (fig 1d). Circulation (2021) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:100; fig 5
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples at 1:100 (fig 5). Biomedicines (2021) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 5a
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5a). Theranostics (2021) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; loading ...; fig 2b
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples (fig 2b). Invest Ophthalmol Vis Sci (2021) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; loading ...; fig 4d
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples (fig 4d). Biol Open (2021) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:200; loading ...; fig 3a
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples at 1:200 (fig 3a). Int J Mol Sci (2020) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6e
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on mouse samples (fig 6e). Br J Pharmacol (2020) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry - paraffin section on human samples (fig 1e). J Clin Invest (2020) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s1c
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s1c). Aging Cell (2020) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; loading ...; fig 6h
Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples (fig 6h). Nature (2019) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; fig 4c
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples (fig 4c). Oncogene (2020) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; fig 1b
Dako HBA2 antibody (DAKO, M082329) was used in immunocytochemistry on human samples (fig 1b). Nature (2019) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; fig 1g
Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples (fig 1g). Fluids Barriers CNS (2018) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:100; fig 4
Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples at 1:100 (fig 4). J Neurotrauma (2018) ncbi
mouse monoclonal (JC70A)
  • other; human; loading ...; fig 4c
Dako HBA2 antibody (Dako, M0823) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:100; loading ...; fig 3e
Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples at 1:100 (fig 3e). Nat Commun (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3f
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on mouse samples (fig 3f). Cancer Res (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:200; loading ...; fig 4a
In order to develop an in vitro method to generate a 3D human lymphatic network within native connective tissue devoid of any exogenous material, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples at 1:200 (fig 4a). Nat Protoc (2017) ncbi
mouse monoclonal (JC70A)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Dako HBA2 antibody (Dako, M0823) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:50; loading ...; fig 1b
In order to examine if endothelial and smooth muscle cells acquired from post-surgically discarded cardiac tissue can be used in cell replacement therapy, Dako HBA2 antibody (DAKO, M0823) was used in immunocytochemistry on human samples at 1:50 (fig 1b). J Transl Med (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 2 ug/ml; loading ...; fig st4
  • immunohistochemistry - paraffin section; African green monkey; 2 ug/ml; loading ...; fig st4
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples at 2 ug/ml (fig st4) and in immunohistochemistry - paraffin section on African green monkey samples at 2 ug/ml (fig st4). J Toxicol Pathol (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:20; loading ...; fig 1d,2d
In order to analyze the importance of canonical Hedgehog signaling within the primary cilia+ liver progenitor cell population in humans, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples at 1:20 (fig 1d,2d). PLoS ONE (2017) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:100; fig 2b
In order to examine the contribution of vascular smooth muscle cell-derived endosialin to atherosclerosis, Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples at 1:100 (fig 2b). Arterioscler Thromb Vasc Biol (2017) ncbi
mouse monoclonal (JC70A)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Dako HBA2 antibody (Dako, M0823) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:10; tbl 2
In order to discuss superficial acral fibromyxoma, Dako HBA2 antibody (Dako, JC/70A) was used in immunohistochemistry - paraffin section on human samples at 1:10 (tbl 2). Am J Dermatopathol (2017) ncbi
mouse monoclonal (JC70A)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Dako HBA2 antibody (Dako, M0823) was used in western blot on human samples . Cell Syst (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:100; fig 5b
In order to discuss how c-jun regulates astrocyte elevated gene-1 in gliomas, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5b). Mol Cell Biol (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 4c
Dako HBA2 antibody (DAKO, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4c). BMC Cancer (2016) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:20
In order to identify and characterize a novel exosomal protein, myoferlin, Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples at 1:20. Oncotarget (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4b
In order to discuss the relevance of vasculogenic mimicry in small cell lung cancer, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4b). Nat Commun (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; pigs ; fig 3b
  • flow cytometry; pigs ; fig s2
In order to evaluate stable and cell supportive small-caliber arterial extracellular matrix grafts in vivo, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - frozen section on pigs samples (fig 3b) and in flow cytometry on pigs samples (fig s2). Tissue Eng Part A (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:30; loading ...; fig 3e
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples at 1:30 (fig 3e). Nat Med (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:50; loading ...
In order to present the case of a patient with gingival and both palatine tonsils localization of a grade-two angiosarcoma, Dako HBA2 antibody (Dako, JC/70A) was used in immunohistochemistry on human samples at 1:50. Rare Tumors (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Anticancer Res (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
In order to characterize alterations in fibroblast populations in the skin of patients with systemic sclerosis, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples (fig s1). Am J Pathol (2016) ncbi
mouse monoclonal (JC70A)
  • western blot; human; loading ...; fig 1d
In order to study the effects of herceptin and doxorubicin on tight junction function, Dako HBA2 antibody (Dako, M082329-2) was used in western blot on human samples (fig 1d). Biol Open (2016) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; fig 4
Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples (fig 4). Biol Open (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; fig 1
Dako HBA2 antibody (Dako, M823) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:40; loading ...; tbl 2
In order to perform an immunohistochemical analysis on 25 cases of littoral cell angioma, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:40 (tbl 2). Histopathology (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:50; loading ...; fig 6d
In order to elucidate the mechanisms that promote disuse-induced insulin resistance, Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry on human samples at 1:50 (fig 6d). Diabetes (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; loading ...; fig 1b
In order to compare the functional angiogenic ability of human aortic endothelial cells and human umbilical vein endothelial cells in a three dimensional system, Dako HBA2 antibody (DAKO, M082301) was used in immunohistochemistry on human samples (fig 1b). Sci Rep (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:100; fig s14
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s14). Nat Commun (2016) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 10 ug/ml; fig 1
In order to assess how spore movement of Bacillus anthracis does not require a carrier cell and is not affected by lethal toxin in human lung models, Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples at 10 ug/ml (fig 1). Microbes Infect (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; 1:200; fig 4
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 4). EMBO Mol Med (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; fig 2b
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples (fig 2b). Mol Vis (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; 1:25; loading ...; fig 1
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - frozen section on human samples at 1:25 (fig 1). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 8b
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1d
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 8b) and in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1d). J Clin Invest (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; 1:25; fig 1
Dako HBA2 antibody (dako, M0823) was used in immunohistochemistry - frozen section on human samples at 1:25 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; fig 3
Dako HBA2 antibody (DAKO/Agilent Technologies, JC70A) was used in immunohistochemistry - frozen section on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; 1:50; loading ...; tbl 1
In order to examine immune cells and chemokines present in human second-trimester fetal skin, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - frozen section on human samples at 1:50 (tbl 1). Wound Repair Regen (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; fig 3a
Dako HBA2 antibody (Dako, JC/70A) was used in immunohistochemistry on human samples (fig 3a). Pathol Res Pract (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:30; fig 3
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:30 (fig 3). J Neuroimmune Pharmacol (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:50; fig 2
In order to determine the mechanisms of bevacizumab resistance, Dako HBA2 antibody (Dako, MO823) was used in immunohistochemistry on human samples at 1:50 (fig 2). Brain Tumor Pathol (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; dogs; 1:20; fig 1
In order to investigate the contribution of COX-2 to canine mammary tumorigenesis, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on dogs samples at 1:20 (fig 1). Vet Comp Oncol (2017) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:200; fig 6
In order to report angiopoietin-2 as a target in both naive and bevacizumab-treated glioblastoma, Dako HBA2 antibody (DAKO, JC704) was used in immunohistochemistry on human samples at 1:200 (fig 6). EMBO Mol Med (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; fig 1d
In order to analyze inhibition of hypoxia inducible factor 1 and acriflavine in sensitizing perihilar cholagiocarcinomas to photodynamic therapy, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; fig 1e
Dako HBA2 antibody (Dako, JC10A) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Nat Med (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; mouse; 1:60; fig s2
Dako HBA2 antibody (DAKO, JC70A) was used in immunohistochemistry on mouse samples at 1:60 (fig s2). Nat Commun (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; fig 1
In order to determine Aqp4 expression and localization following cerebral ischemia in white matter, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples (fig 1). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:25; fig 1 A-i
In order to report that resistance training leads to a decline in pericyte quantity and to an increase in mesenchymal progenitor cell proliferation, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples at 1:25 (fig 1 A-i). J Appl Physiol (1985) (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; dogs; 1:20
In order to study malignant canine mammary tumors and intratumoral CD3+ T-lymphocytes immunoexpression and the association with agiogenesis, c-Kit, and overall survival, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on dogs samples at 1:20. Anal Cell Pathol (Amst) (2015) ncbi
mouse monoclonal (JC70A)
  • western blot; rhesus macaque; 1:250; fig 8
Dako HBA2 antibody (DakoCytomation, M0823) was used in western blot on rhesus macaque samples at 1:250 (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:20; fig 3f
In order to optimize conditions to promote the proliferation of multipotent cardiovascular progenitor cells, Dako HBA2 antibody (DAKO, M0823) was used in immunocytochemistry on human samples at 1:20 (fig 3f). Nat Biotechnol (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:40; tbl 2
Dako HBA2 antibody (Dako, JC/70A) was used in immunohistochemistry - paraffin section on human samples at 1:40 (tbl 2). Med Mol Morphol (2016) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:80; tbl s4
In order to study the involvement of COX/mPGES-1/PGE2 pathway in tumor inflammatory environment, Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry on human samples at 1:80 (tbl s4). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; tbl 2
In order to assess the effect of low-level light irradiation prior to transplantation of adipose-derived stromal cell spheroids on a skin wound model, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples (tbl 2). PLoS ONE (2015) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; fig 1
In order to develop a protocol to generate brain microvascular endothelial-like cells from human induced pluripotent stem cells, Dako HBA2 antibody (Dako, JC70A) was used in immunocytochemistry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:20; fig 1
In order to characterize angiogenic markers and protein and gene expression in oral squamous cell carcinoma, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 1). Head Face Med (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to develop and characterize patient-derived primary xenografts to a model of muscle invasive bladder cancer, Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:40; fig 6
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry on human samples at 1:40 (fig 6). Lab Invest (2015) ncbi
mouse monoclonal (JC70A)
  • western blot; human; 1:1000
  • immunohistochemistry; mouse; 1:500
Dako HBA2 antibody (Dako, M082329) was used in western blot on human samples at 1:1000 and in immunohistochemistry on mouse samples at 1:500. Am J Pathol (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; fig S6
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples (fig S6). PLoS ONE (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human
Dako HBA2 antibody (Dako, clone JC70A) was used in immunohistochemistry on human samples . Brain Tumor Pathol (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; mouse; 1:100
  • immunohistochemistry; human; 1:100
In order to develop a 3D human skin equivalent containing blood and lymph-like capillary networks, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on mouse samples at 1:100 and in immunohistochemistry on human samples at 1:100. J Biomed Mater Res A (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; loading ...; fig 2j
In order to propose that CCL7 is a driver of TNF-alpha-dependent T cell-mediated inflammation in lesional psoriatic skin, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples (fig 2j). Exp Dermatol (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; loading ...; fig 4
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry on human samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; Chlamydomonas reinhardtii; 1:40
Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on Chlamydomonas reinhardtii samples at 1:40. Endocrinology (2015) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; pigs ; 1:50
In order to describe a bronchial wall coculture model using decellularized, porcine luminal trachea membrane and three relevant human cell types, Dako HBA2 antibody (Dako, M 0823) was used in immunocytochemistry on pigs samples at 1:50. Tissue Eng Part C Methods (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human
Dako HBA2 antibody (Dako, JC/70A) was used in immunohistochemistry on human samples . Mol Immunol (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; fig s5a
In order to establish a new method to transplant human fetal kidneys into adult rats, Dako HBA2 antibody (M0823, Dako) was used in immunohistochemistry on human samples (fig s5a). Am J Transplant (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:100
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:100. BMC Dev Biol (2015) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:100; fig 3
Dako HBA2 antibody (Dako, M082301) was used in immunocytochemistry on human samples at 1:100 (fig 3). Nat Cell Biol (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; mouse; fig 4
In order to test if targeting BAI1 and Nestin is beneficial in a mouse model of breast cancer brain metastases, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on mouse samples (fig 4). Mol Cancer Ther (2015) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; mouse
Dako HBA2 antibody (DAKO, JC70A) was used in immunocytochemistry on mouse samples . J Autoimmun (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:100
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples at 1:100. J Cutan Pathol (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:50
In order to evaluate thrombi from patients with ST-elevation myocardial infarction, Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry on human samples at 1:50. Thromb Res (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:20
Dako HBA2 antibody (DAKO, clone JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:20. Pathol Res Pract (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; 1:200
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - frozen section on human samples at 1:200. J Comp Neurol (2015) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; fig s1
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry on human samples (fig s1). Cell (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; fig 6
In order to test if hepatocytes produce MMPs, regulated by CD147, that remodel fibrotic extracellular matrix independent of HSC, Dako HBA2 antibody (Dako Cytomation, JC70A) was used in immunohistochemistry - frozen section on human samples (fig 6). PLoS ONE (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:50
Dako HBA2 antibody (DAKO, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:50. Pancreas (2015) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human
In order to isolate and characterize PDGFR-beta(+) perivascular cells from infantile hemangioma, Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples . Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 1:30
In order to study the genetic profiles of morphologically indistinguishable primary and secondary angiosarcomas, Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry on human samples at 1:30. Br J Cancer (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; mouse; 1:50
Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. Tissue Eng Part A (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:30
Dako HBA2 antibody (DAKO, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:30. Pathol Res Pract (2014) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; domestic rabbit; 1:100
Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on domestic rabbit samples at 1:100. BMC Musculoskelet Disord (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:20
In order to study the expression and role of CXCR2 and SOCS3 in renal cell carcinoma aggresiveness and metastasis, Dako HBA2 antibody (DAKO, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:20. BMC Cancer (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:25; fig s1
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig s1). PLoS ONE (2013) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry - frozen section; mouse
Dako HBA2 antibody (DakoCytomation, M0823) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry - frozen section on mouse samples . PLoS ONE (2013) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - frozen section; human; 0.5 ug/ml
Dako HBA2 antibody (Dako, M082301) was used in immunohistochemistry - frozen section on human samples at 0.5 ug/ml. Neuropathol Appl Neurobiol (2014) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:100
Dako HBA2 antibody (DAKO, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:100. Neurobiol Dis (2013) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human; 5 ug/ml
Dako HBA2 antibody (DAKO, M0823) was used in immunohistochemistry on human samples at 5 ug/ml. PLoS ONE (2013) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry; human
Dako HBA2 antibody (DakoCytomation, M 0823) was used in immunohistochemistry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (JC70A)
  • immunocytochemistry; human; 1:50
In order to study the role of endothelial cells in myofiber differentiation and the development of bioengineered muscle tissue in vivo, Dako HBA2 antibody (Dako, M0823) was used in immunocytochemistry on human samples at 1:50. Biomaterials (2013) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:20
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:20. Histopathology (2013) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human
  • immunocytochemistry; human
In order to test if MSCs in hemangioma also reside in the perivascular region, Dako HBA2 antibody (Dako, M0823) was used in immunohistochemistry - paraffin section on human samples and in immunocytochemistry on human samples . Pediatr Dev Pathol (2012) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human; 1:200
Dako HBA2 antibody (DakoCytomation, JC70A) was used in immunohistochemistry - paraffin section on human samples at 1:200. J Am Acad Dermatol (2010) ncbi
mouse monoclonal (JC70A)
  • immunohistochemistry - paraffin section; human
Dako HBA2 antibody (Dako, JC70A) was used in immunohistochemistry - paraffin section on human samples . Mediators Inflamm (2009) ncbi
BD Biosciences
mouse monoclonal (WM59)
  • flow cytometry; human; 1:20; loading ...; fig 2a, s5a
BD Biosciences HBA2 antibody (BD Biosciences, 555446) was used in flow cytometry on human samples at 1:20 (fig 2a, s5a). Cells (2022) ncbi
mouse monoclonal (L133.1)
  • immunohistochemistry; mouse; loading ...; fig s1b
BD Biosciences HBA2 antibody (BD Biosciences, 340297) was used in immunohistochemistry on mouse samples (fig s1b). J Hematol Oncol (2021) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; human; loading ...; fig 2h
BD Biosciences HBA2 antibody (Beckton Dickenson (BD), 555444) was used in immunocytochemistry on human samples (fig 2h). Cell J (2021) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:1000; loading ...; fig 1a
BD Biosciences HBA2 antibody (BD, 563651) was used in flow cytometry on human samples at 1:1000 (fig 1a). elife (2021) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s1b
BD Biosciences HBA2 antibody (BD, 550389) was used in immunohistochemistry - frozen section on mouse samples (fig s1b). Cell Rep (2021) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:4000; loading ...; fig 1f
BD Biosciences HBA2 antibody (BD Pharmingen, 563653) was used in flow cytometry on human samples at 1:4000 (fig 1f). elife (2020) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:20; loading ...
BD Biosciences HBA2 antibody (BD Pharmingen, WM59) was used in flow cytometry on human samples at 1:20. Angiogenesis (2020) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:100; loading ...; fig s3a
BD Biosciences HBA2 antibody (BD, 560984) was used in flow cytometry on human samples at 1:100 (fig s3a). Nat Commun (2020) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences HBA2 antibody (BD Bioscience, 555446) was used in flow cytometry on human samples (fig 1b). World J Stem Cells (2020) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig s2b
BD Biosciences HBA2 antibody (BD Pharmingen, WM59) was used in flow cytometry on human samples (fig s2b). Sci Rep (2019) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences HBA2 antibody (BD, 555445) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 9d
BD Biosciences HBA2 antibody (BD Pharmigen, WM59) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 9d). J Cell Biol (2019) ncbi
mouse monoclonal (M89D3)
  • flow cytometry; human; fig s2a
BD Biosciences HBA2 antibody (BD, 558094) was used in flow cytometry on human samples (fig s2a). Nature (2019) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences HBA2 antibody (BD Biosciences, WM59) was used in flow cytometry on human samples (fig 2b). J Immunol (2019) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry - frozen section; human; loading ...; fig 3d
BD Biosciences HBA2 antibody (BD Biosciences, WM59) was used in immunohistochemistry - frozen section on human samples (fig 3d). J Infect Dis (2018) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences HBA2 antibody (BD Biosciences, WM59) was used in flow cytometry on human samples (fig s1b). PLoS ONE (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences HBA2 antibody (BD, WM59) was used in flow cytometry on human samples (fig 1c). Nature (2017) ncbi
mouse monoclonal (WM59)
In order to test if high protein affects monocytes during weight loss, BD Biosciences HBA2 antibody (BD Pharmingen, 555445) was used . Nutr Res (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig s4c
BD Biosciences HBA2 antibody (BD Pharmingen, 555445) was used in flow cytometry on human samples (fig s4c). Hum Mol Genet (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:50; loading ...; tbl 1
BD Biosciences HBA2 antibody (Becton, 555446) was used in flow cytometry on human samples at 1:50 (tbl 1). Sci Rep (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig s1c
BD Biosciences HBA2 antibody (BD Biosciences, WM-59) was used in flow cytometry on human samples (fig s1c). Immun Ageing (2017) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; human; loading ...; fig s1
BD Biosciences HBA2 antibody (BD Pharmingen, 555445) was used in immunocytochemistry on human samples (fig s1). PLoS ONE (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig 1a
In order to determine that human basal stem cells isolated from heavy smokers proliferate extensively, whereas their alveolar progenitor cell counterparts have limited colony-forming capacity, BD Biosciences HBA2 antibody (BD Pharmingen, WM59) was used in flow cytometry on human samples (fig 1a). PLoS Biol (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 1b
In order to evaluate the myogenic potential and proliferative capacity of human alveolar mucosa cells, BD Biosciences HBA2 antibody (BD Pharmingen, 560984) was used in flow cytometry on human samples (fig 1b). Cell Cycle (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig 2d
In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, BD Biosciences HBA2 antibody (BD Bioscience, WM59) was used in flow cytometry on human samples (fig 2d). Stem Cells (2017) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; tbl 1
  • immunohistochemistry; human; loading ...; fig 1f
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences HBA2 antibody (BD Bioscience, 555446) was used in flow cytometry on human samples (tbl 1) and in immunohistochemistry on human samples (fig 1f). Sci Rep (2017) ncbi
mouse monoclonal (M89D3)
  • flow cytometry; human; loading ...; fig s3g
In order to demonstrate that iPS-derived cardiomyocytes with a heterozygous GATA4-G296S missense mutation show impaired contractility, calcium handling, and metabolic activity, BD Biosciences HBA2 antibody (BD, BD-558068) was used in flow cytometry on human samples (fig s3g). Cell (2016) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry; human; fig 7
In order to assess the vascular response during Abraxane and cisplatin therapy using Dynamic contrast enhanced-magnetic resonance imaging, BD Biosciences HBA2 antibody (BD Biosciences, 550389) was used in immunohistochemistry on human samples (fig 7). PLoS ONE (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 1
BD Biosciences HBA2 antibody (BD Pharmingen, 555445) was used in flow cytometry on human samples (fig 1). Transl Psychiatry (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 2
BD Biosciences HBA2 antibody (BD Biosciences, 555445) was used in flow cytometry on human samples (fig 2). Biomed Res Int (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:50; fig s9b
In order to assess the efficacy of activated protein C variants for the treatment of stroke, BD Biosciences HBA2 antibody (BD Pharmingen, 555446) was used in flow cytometry on human samples at 1:50 (fig s9b). Nat Med (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 2
In order to study the role of kif3a in dental mesenchymal stem and precursor cell differentiation, BD Biosciences HBA2 antibody (BD Biosciences, 555445) was used in flow cytometry on human samples (fig 2). Mol Med Rep (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 2
BD Biosciences HBA2 antibody (BD Pharmingen, WM59) was used in flow cytometry on human samples (fig 2). Cytotherapy (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig s4
In order to assess the effects of lenalidomide on normal human plasma cell generation, BD Biosciences HBA2 antibody (BD Biosciences, WM59) was used in flow cytometry on human samples (fig s4). Oncotarget (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig s1
BD Biosciences HBA2 antibody (BD Biosciences, 555446) was used in flow cytometry on human samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences HBA2 antibody (BD, 555446) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences HBA2 antibody (BD Pharmingen, BD555446) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 2a
In order to identify and characterize endothelial colony-forming cells in the micro- and macrovasculature of normal, term human placenta, BD Biosciences HBA2 antibody (BD Pharmingen, 560983) was used in flow cytometry on human samples (fig 2a). Stem Cells Transl Med (2016) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry; mouse; 1:100; fig 6
BD Biosciences HBA2 antibody (Becton Dickinson, 555445) was used in immunohistochemistry on mouse samples at 1:100 (fig 6). Nat Commun (2016) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; human; 1:50; fig s5
BD Biosciences HBA2 antibody (BD Pharmingen, 555445) was used in immunocytochemistry on human samples at 1:50 (fig s5). Cell Res (2016) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; rat; 1:40; fig 2
In order to assess the role of platelet endothelial cell adhesion molecule-1 cleavage in delayed microvascular shear adaptation in pulmonary arterial hypertension, BD Biosciences HBA2 antibody (BD Biosciences, 550389) was used in immunocytochemistry on rat samples at 1:40 (fig 2). Am J Respir Crit Care Med (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; tbl 2
In order to study human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue, BD Biosciences HBA2 antibody (BD Pharmingen, 555446) was used in flow cytometry on human samples (tbl 2). Int J Mol Med (2016) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; tbl 1
In order to determine support for heparin-free mesenchymal stem cell propagation in human platelet lysate by mechanical fibrinogen-depletion, BD Biosciences HBA2 antibody (Becton Dickinson, WM59) was used in flow cytometry on human samples (tbl 1). J Transl Med (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences HBA2 antibody (BD, 555445) was used in flow cytometry on human samples (fig 1c). Cytotherapy (2016) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; human; 1:500; fig 2
In order to create and characterize a model for kidney disease using CRISPR-mutants, BD Biosciences HBA2 antibody (BD Biosciences, 555444) was used in immunocytochemistry on human samples at 1:500 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; human; 1:300
In order to evaluate the kidney organoids from human iPS cells, BD Biosciences HBA2 antibody (BD Pharmingen, 555444) was used in immunocytochemistry on human samples at 1:300. Nature (2015) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; human; 1:100; fig s3
In order to research human iPS-derived motor neurons from sporadic ALS patients for gene expression and a strong association between neurodegeneration and mitochondrial functions, BD Biosciences HBA2 antibody (BD Pharmingen, 550389) was used in immunocytochemistry on human samples at 1:100 (fig s3). Front Cell Neurosci (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 2
BD Biosciences HBA2 antibody (BD Biosciences, 561653) was used in flow cytometry on human samples (fig 2). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
In order to investigate how xenogeneic-free conditions affect the therapeutic capacity of peripheral blood-derived endothelial-colony cells, BD Biosciences HBA2 antibody (BD Biosciences, 555446) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (M89D3)
  • flow cytometry; human; fig s4
BD Biosciences HBA2 antibody (BD Pharmingen, 558094) was used in flow cytometry on human samples (fig s4). Stem Cell Reports (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
In order to discuss the contribution of missense mutations in PDE3A to hypertension, BD Biosciences HBA2 antibody (BD Biosciences, 555445) was used in flow cytometry on human samples . Nat Genet (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 5
BD Biosciences HBA2 antibody (BD Bioscience, WM59) was used in flow cytometry on human samples (fig 5). Nat Immunol (2015) ncbi
mouse monoclonal (WM59)
  • western blot; mouse
BD Biosciences HBA2 antibody (BD, WM59) was used in western blot on mouse samples . Nature (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
In order to report that L3MBTL1 represses the ability of stem cells to drive hematopoietic-specific transcriptional programs via SMAD5 and impairing its recruitment to target regulatory regions, BD Biosciences HBA2 antibody (BD, BD555446) was used in flow cytometry on human samples . Stem Cell Reports (2015) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry - paraffin section; human
  • flow cytometry; human; fig s1
  • immunocytochemistry; human
BD Biosciences HBA2 antibody (BD Biosciences, 560983) was used in immunohistochemistry - paraffin section on human samples , in flow cytometry on human samples (fig s1) and in immunocytochemistry on human samples . J Transl Med (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (B.D. Biosciences, 561654) was used in flow cytometry on human samples . World J Stem Cells (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 4
BD Biosciences HBA2 antibody (BD Biosciences Pharmingen, WM-59) was used in flow cytometry on human samples (fig 4). Cytotherapy (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:50
BD Biosciences HBA2 antibody (BD, 555446) was used in flow cytometry on human samples at 1:50. Stem Cells (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (Becton Dickinson, WM59) was used in flow cytometry on human samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:50
BD Biosciences HBA2 antibody (BD, 555445) was used in flow cytometry on human samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 5
BD Biosciences HBA2 antibody (BD Biosciences, WM59) was used in flow cytometry on human samples (fig 5). J Leukoc Biol (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (BD Biosciences, 55445) was used in flow cytometry on human samples . Tissue Eng Part A (2015) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (BD Pharmingen, WM59) was used in flow cytometry on human samples . Nat Biotechnol (2014) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; mouse
BD Biosciences HBA2 antibody (PharMingen, WM59) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (BD Biosciences, WM-59) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (Becton Dickinson, 555445) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (BD, 560984) was used in flow cytometry on human samples . Cell Tissue Res (2014) ncbi
mouse monoclonal (M89D3)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BD Biosciences HBA2 antibody (BD, M89D3) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (WM59)
  • immunocytochemistry; human; 1:200
In order to study cord blood as a source of circulating endothelial progenitor cells that can be directed towards specialized endothelial phenotypes, BD Biosciences HBA2 antibody (BD Pharmingen, 550389) was used in immunocytochemistry on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human
BD Biosciences HBA2 antibody (BD Biosciences, 555446) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry; human
In order to investigate the thymus development, BD Biosciences HBA2 antibody (BD, WM59) was used in immunohistochemistry on human samples . Development (2013) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; fig 1
BD Biosciences HBA2 antibody (BD, WM59) was used in flow cytometry on human samples (fig 1). J Tissue Eng Regen Med (2015) ncbi
mouse monoclonal (L133.1)
  • flow cytometry; human
BD Biosciences HBA2 antibody (BD Biosciences, L133.1) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; tbl 2
BD Biosciences HBA2 antibody (BD Biosciences, 555446) was used in flow cytometry on human samples (tbl 2). PLoS ONE (2012) ncbi
mouse monoclonal (WM59)
  • flow cytometry; human; 1:5
  • immunocytochemistry; human; 1:5
BD Biosciences HBA2 antibody (BD Pharmingen, WM-59) was used in flow cytometry on human samples at 1:5 and in immunocytochemistry on human samples at 1:5. Microvasc Res (2012) ncbi
mouse monoclonal (WM59)
  • immunohistochemistry - paraffin section; human; 1:200
BD Biosciences HBA2 antibody (BD Biosciences, WM59) was used in immunohistochemistry - paraffin section on human samples at 1:200. Biomarkers (2012) ncbi
Articles Reviewed
  1. Ghochani Y, Muthukrishnan S, Sohrabi A, Kawaguchi R, Condro M, Bastola S, et al. A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration. Cell Rep. 2022;41:111511 pubmed publisher
  2. Hauke M, Eckenstaler R, Ripperger A, Ender A, Braun H, Benndorf R. Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells. J Am Heart Assoc. 2022;11:e025119 pubmed publisher
  3. R xfc tsche D, Michalak Mićka K, Zielinska D, Moll H, Moehrlen U, Biedermann T, et al. The Role of CD200-CD200 Receptor in Human Blood and Lymphatic Endothelial Cells in the Regulation of Skin Tissue Inflammation. Cells. 2022;11: pubmed publisher
  4. Dai J, Cimino P, Gouin K, Grzelak C, Barrett A, Lim A, et al. Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain. Nat Cancer. 2022;3:25-42 pubmed publisher
  5. Hsieh L, Dos Santos S, Hall B, Ogbechi J, Loglo A, Salguero F, et al. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions. PLoS Pathog. 2022;18:e1010280 pubmed publisher
  6. Sáinz Jaspeado M, Smith R, Plunde O, Pawelzik S, Jin Y, Nordling S, et al. Palmdelphin Regulates Nuclear Resilience to Mechanical Stress in the Endothelium. Circulation. 2021;144:1629-1645 pubmed publisher
  7. Lee J, Hur J, Kwon Y, Chae C, Choi J, Hwang I, et al. KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state. J Hematol Oncol. 2021;14:148 pubmed publisher
  8. Aleksandrovych V, Wrona A, Bereza T, Pitynski K, Gil K. Oviductal Telocytes in Patients with Uterine Myoma. Biomedicines. 2021;9: pubmed publisher
  9. Qin Z, Liu F, Blair R, Wang C, Yang H, Mudd J, et al. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics. 2021;11:8076-8091 pubmed publisher
  10. Gholami S, Mazidi Z, Pahlavan S, Moslem F, Hosseini M, Taei A, et al. A Novel Insight into Endothelial and Cardiac Cells Phenotype in Systemic Sclerosis Using Patient-Derived Induced Pluripotent Stem Cell. Cell J. 2021;23:273-287 pubmed publisher
  11. Abu El Asrar A, Nawaz M, Ahmad A, Siddiquei M, Allegaert E, Gikandi P, et al. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2021;62:32 pubmed publisher
  12. Dieterle M, Solà Riera C, Ye C, Goodfellow S, Mittler E, Kasikci E, et al. Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells. elife. 2021;10: pubmed publisher
  13. Prater M, Hamilton R, Wa Yung H, Sharkey A, Robson P, Abd Hamid N, et al. RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first-second trimester transition. Biol Open. 2021;10: pubmed publisher
  14. Zhang X, Yu K, Ma L, Qian Z, Tian X, Miao Y, et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. Theranostics. 2021;11:5650-5674 pubmed publisher
  15. Georgopoulou D, Callari M, Rueda O, Shea A, Martin A, Giovannetti A, et al. Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response. Nat Commun. 2021;12:1998 pubmed publisher
  16. Philips T, Mironova Y, Jouroukhin Y, Chew J, Vidensky S, Farah M, et al. MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degeneration. Cell Rep. 2021;34:108610 pubmed publisher
  17. Gerrits T, Zandbergen M, Wolterbeek R, Bruijn J, Baelde H, Scharpfenecker M. Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy. Int J Mol Sci. 2020;21: pubmed publisher
  18. Xu J, Wang Y, Hsu C, Negri S, Tower R, Gao Y, et al. Lysosomal protein surface expression discriminates fat- from bone-forming human mesenchymal precursor cells. elife. 2020;9: pubmed publisher
  19. Tacconi C, He Y, Ducoli L, Detmar M. Epigenetic regulation of the lineage specificity of primary human dermal lymphatic and blood vascular endothelial cells. Angiogenesis. 2020;: pubmed publisher
  20. Suzuki K, Okada H, Takemura G, Takada C, Tomita H, Yano H, et al. Recombinant thrombomodulin protects against LPS-induced acute respiratory distress syndrome via preservation of pulmonary endothelial glycocalyx. Br J Pharmacol. 2020;177:4021-4033 pubmed publisher
  21. Kim J, Yang Y, Park K, Ge X, Xu R, Li N, et al. A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation. Nat Commun. 2020;11:2289 pubmed publisher
  22. Dmitrieva N, Walts A, Nguyen D, Grubb A, Zhang X, Wang X, et al. Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome. J Clin Invest. 2020;130:4167-4181 pubmed publisher
  23. Gao K, He S, Kumar P, Farmer D, Zhou J, Wang A. Clonal isolation of endothelial colony-forming cells from early gestation chorionic villi of human placenta for fetal tissue regeneration. World J Stem Cells. 2020;12:123-138 pubmed publisher
  24. Foster A, El Chami C, O Neill C, Watson R. Osmolyte transporter expression is reduced in photoaged human skin: Implications for skin hydration in aging. Aging Cell. 2020;19:e13058 pubmed publisher
  25. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  26. Veschi V, Mangiapane L, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987-1003 pubmed publisher
  27. Avril M, Benjamin M, Dols M, Smith J. Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption. Sci Rep. 2019;9:13142 pubmed publisher
  28. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  29. Mason D, Collins J, Dawahare J, Nguyen T, Lin Y, Voytik Harbin S, et al. YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility. J Cell Biol. 2019;218:1369-1389 pubmed publisher
  30. Wimmer R, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019;565:505-510 pubmed publisher
  31. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed publisher
  32. Patel N, Vukmanovic Stejic M, Suárez Fariñas M, Chambers E, Sandhu D, Fuentes Duculan J, et al. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge. J Infect Dis. 2018;218:S88-S98 pubmed publisher
  33. Wevers N, Kasi D, Gray T, Wilschut K, Smith B, van Vught R, et al. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport. Fluids Barriers CNS. 2018;15:23 pubmed publisher
  34. Castro L, Noelia M, Vidal Jorge M, Sanchez Ortiz D, Gándara D, Martínez Sáez E, et al. Kir6.2, the Pore-Forming Subunit of ATP-Sensitive K+ Channels, Is Overexpressed in Human Posttraumatic Brain Contusions. J Neurotrauma. 2018;: pubmed publisher
  35. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  36. Chen X, Janssen J, Liu J, Maggio I, t Jong A, Mikkers H, et al. In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat Commun. 2017;8:657 pubmed publisher
  37. de Wolf A, van Aalst S, Ludwig I, Bodinham C, Lewis D, van der Zee R, et al. Regulatory T cell frequencies and phenotypes following anti-viral vaccination. PLoS ONE. 2017;12:e0179942 pubmed publisher
  38. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  39. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed publisher
  40. Kim J, Lin G, Zhou J, Mund J, Case J, Campbell W. Weight loss achieved using an energy restriction diet with normal or higher dietary protein decreased the number of CD14++CD16+ proinflammatory monocytes and plasma lipids and lipoproteins in middle-aged, overweight, and obese adults. Nutr Res. 2017;40:75-84 pubmed publisher
  41. Gibot L, Galbraith T, Bourland J, Rogic A, Skobe M, Auger F. Tissue-engineered 3D human lymphatic microvascular network for in vitro studies of lymphangiogenesis. Nat Protoc. 2017;12:1077-1088 pubmed publisher
  42. Miller E, Kobayashi G, Musso C, Allen M, Ishiy F, de Caires L, et al. EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome. Hum Mol Genet. 2017;26:2177-2191 pubmed publisher
  43. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  44. Di Maggio N, Martella E, Frismantiene A, Resink T, Schreiner S, Lucarelli E, et al. Extracellular matrix and α5β1 integrin signaling control the maintenance of bone formation capacity by human adipose-derived stromal cells. Sci Rep. 2017;7:44398 pubmed publisher
  45. Zakharova I, Zhiven M, Saaya S, Shevchenko A, Smirnova A, Strunov A, et al. Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts. J Transl Med. 2017;15:54 pubmed publisher
  46. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  47. Saiwaew S, Sritabal J, Piaraksa N, Keayarsa S, Ruengweerayut R, Utaisin C, et al. Effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum infected erythrocytes. PLoS ONE. 2017;12:e0172718 pubmed publisher
  48. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  49. Grzelak C, Sigglekow N, Tirnitz Parker J, Hamson E, Warren A, Maneck B, et al. Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease. PLoS ONE. 2017;12:e0171480 pubmed publisher
  50. Saha D, Koli S, Patgaonkar M, Reddy K. Expression of hemoglobin-α and β subunits in human vaginal epithelial cells and their functional significance. PLoS ONE. 2017;12:e0171084 pubmed publisher
  51. Hasanov Z, Ruckdeschel T, König C, Mogler C, Kapel S, Korn C, et al. Endosialin Promotes Atherosclerosis Through Phenotypic Remodeling of Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 2017;37:495-505 pubmed publisher
  52. Weeden C, Chen Y, Ma S, Hu Y, Ramm G, Sutherland K, et al. Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway. PLoS Biol. 2017;15:e2000731 pubmed publisher
  53. Zorin V, Pulin A, Eremin I, Korsakov I, Zorina A, Khromova N, et al. Myogenic potential of human alveolar mucosa derived cells. Cell Cycle. 2017;16:545-555 pubmed publisher
  54. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  55. Sontag S, Förster M, Qin J, Wanek P, Mitzka S, Schüler H, et al. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. Stem Cells. 2017;35:898-908 pubmed publisher
  56. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  57. Cullen D, Diaz Recuero J, Cullen R, Rodriguez Peralto J, Kutzner H, Requena L. Superficial Acral Fibromyxoma: Report of 13 Cases With New Immunohistochemical Findings. Am J Dermatopathol. 2017;39:14-22 pubmed publisher
  58. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  59. Ang Y, Rivas R, Ribeiro A, Srivas R, Rivera J, Stone N, et al. Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis. Cell. 2016;167:1734-1749.e22 pubmed publisher
  60. Liu L, Guan H, Li Y, Ying Z, Wu J, Zhu X, et al. Astrocyte Elevated Gene 1 Interacts with Acetyltransferase p300 and c-Jun To Promote Tumor Aggressiveness. Mol Cell Biol. 2017;37: pubmed publisher
  61. Takano M, Shimada K, Fujii T, Morita K, Takeda M, Nakajima Y, et al. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis. BMC Cancer. 2016;16:903 pubmed
  62. Blomme A, Fahmy K, Peulen O, Costanza B, Fontaine M, Struman I, et al. Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget. 2016;7:83669-83683 pubmed publisher
  63. Williamson S, Metcalf R, Trapani F, Mohan S, Antonello J, Abbott B, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322 pubmed publisher
  64. Dahan N, Sarig U, Bronshtein T, Baruch L, Karram T, Hoffman A, et al. Dynamic Autologous Reendothelialization of Small-Caliber Arterial Extracellular Matrix: A Preclinical Large Animal Study. Tissue Eng Part A. 2017;23:69-79 pubmed publisher
  65. Frentzas S, Simoneau E, Bridgeman V, Vermeulen P, Foo S, Kostaras E, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22:1294-1302 pubmed publisher
  66. Chamberland F, Maurina T, Degano Valmary S, Spicarolen T, Chaigneau L. Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization. Rare Tumors. 2016;8:5907 pubmed
  67. Sun X, Yang L, Yan X, Sun Y, Zhao D, Ji Y, et al. DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin. PLoS ONE. 2016;11:e0162601 pubmed publisher
  68. Jankowska Konsur A, Kobierzycki C, Grzegrzolka J, Piotrowska A, Gomulkiewicz A, Glatzel Plucińska N, et al. Expression of CD31 in Mycosis Fungoides. Anticancer Res. 2016;36:4575-82 pubmed
  69. Lopez Vilchez I, Diaz Ricart M, Navarro V, Torramade S, Zamorano León J, Lopez Farre A, et al. Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model. Transl Psychiatry. 2016;6:e886 pubmed publisher
  70. Nazari B, Rice L, Stifano G, Barron A, Wang Y, Korndorf T, et al. Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. Am J Pathol. 2016;186:2650-64 pubmed publisher
  71. Chen N, Xia X, Qin L, Luo L, Han S, Wang G, et al. Effects of 8-Week Hatha Yoga Training on Metabolic and Inflammatory Markers in Healthy, Female Chinese Subjects: A Randomized Clinical Trial. Biomed Res Int. 2016;2016:5387258 pubmed publisher
  72. Wang Y, Zhao Z, Rege S, Wang M, Si G, Zhou Y, et al. 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice. Nat Med. 2016;22:1050-5 pubmed publisher
  73. Wilkinson E, Sidaway J, Cross M. Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability. Biol Open. 2016;5:1362-1370 pubmed publisher
  74. Stanly T, Fritzsche M, Banerji S, Garcia E, Bernardino de la Serna J, Jackson D, et al. Critical importance of appropriate fixation conditions for faithful imaging of receptor microclusters. Biol Open. 2016;5:1343-50 pubmed publisher
  75. Pannier D, Philippin Lauridant G, Baranzelli M, Bertin D, Bogart E, Delprat V, et al. High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer. Oncol Lett. 2016;12:1422-1428 pubmed
  76. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed publisher
  77. Codinach M, Blanco M, Ortega I, Lloret M, Reales L, Coca M, et al. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells. Cytotherapy. 2016;18:1197-208 pubmed publisher
  78. Peckova K, Michal M, Hadravsky L, Suster S, Damjanov I, Miesbauerova M, et al. Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies. Histopathology. 2016;69:762-774 pubmed publisher
  79. Dirks M, Wall B, van de Valk B, Holloway T, Holloway G, Chabowski A, et al. One Week of Bed Rest Leads to Substantial Muscle Atrophy and Induces Whole-Body Insulin Resistance in the Absence of Skeletal Muscle Lipid Accumulation. Diabetes. 2016;65:2862-75 pubmed publisher
  80. Seo H, Jeong H, Joo H, Choi S, Park C, Kim J, et al. Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system. Sci Rep. 2016;6:28832 pubmed publisher
  81. Evrard S, Lecce L, Michelis K, Nomura Kitabayashi A, Pandey G, Purushothaman K, et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun. 2016;7:11853 pubmed publisher
  82. Booth J, Duggan E, Patel V, Langer M, Wu W, Braun A, et al. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models. Microbes Infect. 2016;18:615-626 pubmed publisher
  83. Chen P, Qin L, Li G, Tellides G, Simons M. Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression. EMBO Mol Med. 2016;8:712-28 pubmed publisher
  84. Abu El Asrar A, Siddiquei M, Nawaz M, De Hertogh G, Mohammad G, Alam K, et al. Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy. Mol Vis. 2016;22:424-35 pubmed
  85. Preuße C, Allenbach Y, Hoffmann O, Goebel H, Pehl D, Radke J, et al. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. Acta Neuropathol Commun. 2016;4:45 pubmed publisher
  86. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  87. Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed publisher
  88. Wu S, Rupaimoole R, Shen F, Pradeep S, Pecot C, Ivan C, et al. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. Nat Commun. 2016;7:11169 pubmed publisher
  89. Zou L, Chen Q, Quanbeck Z, Bechtold J, Kaufman D. Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells. Sci Rep. 2016;6:22868 pubmed publisher
  90. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  91. Eriksson J, Le Joncour V, Nummela P, Jahkola T, Virolainen S, Laakkonen P, et al. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression. Oncotarget. 2016;7:15065-92 pubmed publisher
  92. Walraven M, Talhout W, Beelen R, van Egmond M, Ulrich M. Healthy human second-trimester fetal skin is deficient in leukocytes and associated homing chemokines. Wound Repair Regen. 2016;24:533-41 pubmed publisher
  93. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  94. Val Bernal J, Mayorga M, Terán Villagrá N. Extracutaneous intravascular histiocytosis of the aortic valve: Report of two cases. Pathol Res Pract. 2016;212:258-63 pubmed publisher
  95. Buzhdygan T, Lisinicchia J, Patel V, Johnson K, Neugebauer V, Paessler S, et al. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection. J Neuroimmune Pharmacol. 2016;11:279-93 pubmed publisher
  96. Okamoto S, Nitta M, Maruyama T, Sawada T, Komori T, Okada Y, et al. Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas. Brain Tumor Pathol. 2016;33:129-36 pubmed publisher
  97. Solomon I, O Reilly M, Ionescu L, Alphonse R, Rajabali S, Zhong S, et al. Functional Differences Between Placental Micro- and Macrovascular Endothelial Colony-Forming Cells. Stem Cells Transl Med. 2016;5:291-300 pubmed publisher
  98. Heemskerk N, Schimmel L, Oort C, van Rijssel J, Yin T, Ma B, et al. F-actin-rich contractile endothelial pores prevent vascular leakage during leukocyte diapedesis through local RhoA signalling. Nat Commun. 2016;7:10493 pubmed publisher
  99. Carvalho M, Pires I, Prada J, Raposo T, Gregório H, Lobo L, et al. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study. Vet Comp Oncol. 2017;15:619-631 pubmed publisher
  100. Pan H, Guan D, Liu X, Li J, Wang L, Wu J, et al. SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res. 2016;26:190-205 pubmed publisher
  101. Szulcek R, Happé C, Rol N, Fontijn R, Dickhoff C, Hartemink K, et al. Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. Am J Respir Crit Care Med. 2016;193:1410-20 pubmed publisher
  102. Heo J, Choi Y, Kim H, Kim H. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37:115-25 pubmed publisher
  103. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed publisher
  104. Weijer R, Broekgaarden M, Krekorian M, Alles L, van Wijk A, Mackaaij C, et al. Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. Oncotarget. 2016;7:3341-56 pubmed publisher
  105. Laner Plamberger S, Lener T, Schmid D, Streif D, Salzer T, Öller M, et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015;13:354 pubmed publisher
  106. Oliver Vila I, Coca M, Grau Vorster M, Pujals Fonts N, Caminal M, Casamayor Genescà A, et al. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly. Cytotherapy. 2016;18:25-35 pubmed publisher
  107. Freedman B, Brooks C, Lam A, Fu H, Morizane R, Agrawal V, et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun. 2015;6:8715 pubmed publisher
  108. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  109. Giampietro C, Deflorian G, Gallo S, di Matteo A, Pradella D, Bonomi S, et al. The alternative splicing factor Nova2 regulates vascular development and lumen formation. Nat Commun. 2015;6:8479 pubmed publisher
  110. Takasato M, Er P, Chiu H, Maier B, Baillie G, Ferguson C, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015;526:564-8 pubmed publisher
  111. Stokum J, Mehta R, Ivanova S, Yu E, Gerzanich V, Simard J. Heterogeneity of aquaporin-4 localization and expression after focal cerebral ischemia underlies differences in white versus grey matter swelling. Acta Neuropathol Commun. 2015;3:61 pubmed publisher
  112. Farup J, De Lisio M, Rahbek S, Bjerre J, Vendelbo M, Boppart M, et al. Pericyte response to contraction mode-specific resistance exercise training in human skeletal muscle. J Appl Physiol (1985). 2015;119:1053-63 pubmed publisher
  113. Carvalho M, Pires I, Dias M, Prada J, Gregório H, Lobo L, et al. Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors. Anal Cell Pathol (Amst). 2015;2015:920409 pubmed publisher
  114. Alves C, Dariolli R, Jorge F, Monteiro M, Maximino J, Martins R, et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front Cell Neurosci. 2015;9:289 pubmed publisher
  115. Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6:144 pubmed publisher
  116. Kumar P, Thirkill T, Ji J, Monte L, Douglas G. Differential Effects of Sodium Butyrate and Lithium Chloride on Rhesus Monkey Trophoblast Differentiation. PLoS ONE. 2015;10:e0135089 pubmed publisher
  117. Birket M, Ribeiro M, Verkerk A, Ward D, Leitoguinho A, Den Hartogh S, et al. Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells. Nat Biotechnol. 2015;33:970-9 pubmed publisher
  118. Tajima S, Takashi Y, Ito N, Fukumoto S, Fukuyama M. ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. Med Mol Morphol. 2016;49:203-209 pubmed
  119. Larsson K, Kock A, Idborg H, Arsenian Henriksson M, Martinsson T, Johnsen J, et al. COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci U S A. 2015;112:8070-5 pubmed publisher
  120. Tasev D, van Wijhe M, Weijers E, van Hinsbergh V, Koolwijk P. Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity. PLoS ONE. 2015;10:e0129935 pubmed publisher
  121. James S, Fox J, Afsari F, Lee J, Clough S, Knight C, et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15 pubmed publisher
  122. Park I, Chung P, Ahn J. Enhancement of Ischemic Wound Healing by Spheroid Grafting of Human Adipose-Derived Stem Cells Treated with Low-Level Light Irradiation. PLoS ONE. 2015;10:e0122776 pubmed publisher
  123. Minami H, Tashiro K, Okada A, Hirata N, Yamaguchi T, Takayama K, et al. Generation of Brain Microvascular Endothelial-Like Cells from Human Induced Pluripotent Stem Cells by Co-Culture with C6 Glioma Cells. PLoS ONE. 2015;10:e0128890 pubmed publisher
  124. Jung S, Sielker S, Purcz N, Sproll C, Acil Y, Kleinheinz J. Analysis of angiogenic markers in oral squamous cell carcinoma-gene and protein expression. Head Face Med. 2015;11:19 pubmed publisher
  125. Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt A, et al. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Oncotarget. 2015;6:21522-32 pubmed
  126. Maass P, Aydin A, Luft F, Schächterle C, Weise A, Stricker S, et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet. 2015;47:647-53 pubmed publisher
  127. Tsuneki M, Hardee S, Michaud M, Morotti R, Lavik E, Madri J. A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway. Lab Invest. 2015;95:765-80 pubmed publisher
  128. Good R, Gilbane A, Trinder S, Denton C, Coghlan G, Abraham D, et al. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension. Am J Pathol. 2015;185:1850-8 pubmed publisher
  129. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  130. Tate C, Mc Entire J, Pallini R, Vakana E, Wyss L, Blosser W, et al. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology. PLoS ONE. 2015;10:e0125697 pubmed publisher
  131. Nakada S, Minato H, Takegami T, Kurose N, Ikeda H, Kobayashi M, et al. NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases. Brain Tumor Pathol. 2015;32:268-74 pubmed publisher
  132. Matsusaki M, Fujimoto K, Shirakata Y, Hirakawa S, Hashimoto K, Akashi M. Development of full-thickness human skin equivalents with blood and lymph-like capillary networks by cell coating technology. J Biomed Mater Res A. 2015;103:3386-96 pubmed publisher
  133. Brunner P, Glitzner E, Reininger B, Klein I, Stary G, Mildner M, et al. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin. Exp Dermatol. 2015;24:522-8 pubmed publisher
  134. Yarilin D, Xu K, Turkekul M, Fan N, Romin Y, Fijisawa S, et al. Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection. Sci Rep. 2015;5:9534 pubmed publisher
  135. Lechuga T, Zhang H, Sheibani L, Karim M, Jia J, Magness R, et al. Estrogen Replacement Therapy in Ovariectomized Nonpregnant Ewes Stimulates Uterine Artery Hydrogen Sulfide Biosynthesis by Selectively Up-Regulating Cystathionine β-Synthase Expression. Endocrinology. 2015;156:2288-98 pubmed publisher
  136. Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed publisher
  137. Melo E, Kasper J, Unger R, Farré R, Kirkpatrick C. Development of a Bronchial Wall Model: Triple Culture on a Decellularized Porcine Trachea. Tissue Eng Part C Methods. 2015;21:909-21 pubmed publisher
  138. Perna F, Vu L, Themeli M, Kriks S, Hoya Arias R, Khanin R, et al. The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells. Stem Cell Reports. 2015;4:658-69 pubmed publisher
  139. Sei Y, Mizuno M, Suzuki Y, Imai M, Higashide K, Harris C, et al. Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy. Mol Immunol. 2015;65:302-9 pubmed publisher
  140. Chang N, Gu J, Gu S, Osorio R, Concepcion W, Gu E. Arterial flow regulator enables transplantation and growth of human fetal kidneys in rats. Am J Transplant. 2015;15:1692-700 pubmed publisher
  141. Ghiabi P, Jiang J, Pasquier J, Maleki M, Abu Kaoud N, Halabi N, et al. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche. J Transl Med. 2015;13:27 pubmed publisher
  142. Lankford L, Selby T, Becker J, Ryzhuk V, Long C, Farmer D, et al. Early gestation chorionic villi-derived stromal cells for fetal tissue engineering. World J Stem Cells. 2015;7:195-207 pubmed publisher
  143. Heeren A, van Iperen L, Klootwijk D, De Melo Bernardo A, Roost M, Gomes Fernandes M, et al. Development of the follicular basement membrane during human gametogenesis and early folliculogenesis. BMC Dev Biol. 2015;15:4 pubmed publisher
  144. Hou S, Nilchi L, Li X, Gangaraju S, Jiang S, Aylsworth A, et al. Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage. Sci Rep. 2015;5:7890 pubmed publisher
  145. Zhou W, Ke S, Huang Z, Flavahan W, Fang X, Paul J, et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol. 2015;17:170-82 pubmed publisher
  146. Kim H, Huang L, Critser P, Yang Z, Chan R, Wang L, et al. Notch ligand Delta-like 1 promotes in vivo vasculogenesis in human cord blood-derived endothelial colony forming cells. Cytotherapy. 2015;17:579-92 pubmed publisher
  147. Lee S, Lee K, Lee J, Kang S, Kim H, Asahara T, et al. Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling. Stem Cells. 2015;33:1490-500 pubmed publisher
  148. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed publisher
  149. Rohringer S, Holnthoner W, Hackl M, Weihs A, Rünzler D, Skalicky S, et al. Molecular and cellular effects of in vitro shockwave treatment on lymphatic endothelial cells. PLoS ONE. 2014;9:e114806 pubmed publisher
  150. Williams D, Anastos K, Morgello S, Berman J. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97:401-12 pubmed publisher
  151. Meisen W, Dubin S, Sizemore S, Mathsyaraja H, Thies K, Lehman N, et al. Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies. Mol Cancer Ther. 2015;14:307-14 pubmed publisher
  152. Guerrero J, Oliveira H, Catros S, Siadous R, Derkaoui S, Bareille R, et al. The use of total human bone marrow fraction in a direct three-dimensional expansion approach for bone tissue engineering applications: focus on angiogenesis and osteogenesis. Tissue Eng Part A. 2015;21:861-74 pubmed publisher
  153. Prasain N, Lee M, Vemula S, Meador J, Yoshimoto M, Ferkowicz M, et al. Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells. Nat Biotechnol. 2014;32:1151-1157 pubmed publisher
  154. Clement M, Fornasa G, Loyau S, Morvan M, Andreata F, Guedj K, et al. Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo. J Autoimmun. 2015;56:23-33 pubmed publisher
  155. Wang L, Gao T, Wang G. Verrucous hemangioma: a clinicopathological and immunohistochemical analysis of 74 cases. J Cutan Pathol. 2014;41:823-30 pubmed publisher
  156. Kostić J, Orlić D, Borović M, Beleslin B, Milašinović D, Dobrić M, et al. Coronary thrombi neovascularization in patients with ST-elevation myocardial infarction - clinical and angiographic implications. Thromb Res. 2014;134:1038-45 pubmed publisher
  157. Strzępek A, Kaczmarczyk K, Białas M, Szpor J, Dyduch G, Szopiński T, et al. ERG positive prostatic cancer may show a more angiogenetic phenotype. Pathol Res Pract. 2014;210:897-900 pubmed publisher
  158. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  159. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  160. Lowe M, Faull R, Christie D, Waldvogel H. Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity. J Comp Neurol. 2015;523:699-725 pubmed publisher
  161. Jeon Y, Moon K, Park S, Chung D. Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation. Virchows Arch. 2014;465:453-61 pubmed publisher
  162. Scherz Shouval R, Santagata S, Mendillo M, Sholl L, Ben Aharon I, Beck A, et al. The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell. 2014;158:564-78 pubmed publisher
  163. Calabro S, Maczurek A, Morgan A, Tu T, Wen V, Yee C, et al. Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis. PLoS ONE. 2014;9:e90571 pubmed publisher
  164. Lytras D, Leontara V, Kefala M, Foukas P, Giannakou N, Pouliakis A, et al. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome. Pancreas. 2015;44:87-92 pubmed publisher
  165. Yuan S, Guo Y, Zhou X, Shen W, Chen H. PDGFR-? (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo. Int J Clin Exp Pathol. 2014;7:2861-70 pubmed
  166. Styring E, Seinen J, Dominguez Valentin M, Domanski H, Jonsson M, von Steyern F, et al. Key roles for MYC, KIT and RET signaling in secondary angiosarcomas. Br J Cancer. 2014;111:407-12 pubmed publisher
  167. Hellesøy M, Blois A, Tiron C, Mannelqvist M, Akslen L, Lorens J. Akt1 activity regulates vessel maturation in a tissue engineering model of angiogenesis. Tissue Eng Part A. 2014;20:2590-603 pubmed publisher
  168. Changchien Y, Bocskai P, Kovacs I, Hargitai Z, Kollár S, Torok M. Pleomorphic hyalinizing angiectatic tumor of soft parts: case report with unusual ganglion-like cells and review of the literature. Pathol Res Pract. 2014;210:1146-51 pubmed publisher
  169. Fuereder T, Wacheck V, Strommer S, Horak P, Gerschpacher M, Lamm W, et al. Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study. PLoS ONE. 2014;9:e95310 pubmed publisher
  170. Song Y, Stål P, Yu J, Lorentzon R, Backman C, Forsgren S. Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model. BMC Musculoskelet Disord. 2014;15:126 pubmed publisher
  171. Pei M, Li J, Zhang Y, Liu G, Wei L, Zhang Y. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014;356:391-403 pubmed publisher
  172. Stofas A, Levidou G, Piperi C, Adamopoulos C, Dalagiorgou G, Bamias A, et al. The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma. BMC Cancer. 2014;14:149 pubmed publisher
  173. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  174. Boyer Di Ponio J, El Ayoubi F, Glacial F, Ganeshamoorthy K, Driancourt C, Godet M, et al. Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes. PLoS ONE. 2014;9:e84179 pubmed publisher
  175. Emara M, Turner A, Allalunis Turner J. Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells. Int J Oncol. 2014;44:514-20 pubmed publisher
  176. Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed publisher
  177. Jelen S, Parm Ulhøi B, Larsen A, Frøkiær J, Nielsen S, Rutzler M. AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15(+)/CalB(+) leukocytes. PLoS ONE. 2013;8:e75764 pubmed publisher
  178. Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
  179. Farley A, Morris L, Vroegindeweij E, Depreter M, Vaidya H, Stenhouse F, et al. Dynamics of thymus organogenesis and colonization in early human development. Development. 2013;140:2015-26 pubmed publisher
  180. Brana C, Frossard M, Pescini Gobert R, Martinier N, Boschert U, Seabrook T. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2014;40:564-78 pubmed publisher
  181. Iori V, Maroso M, Rizzi M, Iyer A, Vertemara R, Carli M, et al. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis. 2013;58:102-14 pubmed publisher
  182. Brereton M, Wareing M, Jones R, Greenwood S. Characterisation of K+ channels in human fetoplacental vascular smooth muscle cells. PLoS ONE. 2013;8:e57451 pubmed publisher
  183. Denecke B, Horsch L, Radtke S, Fischer J, Horn P, Giebel B. Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering. J Tissue Eng Regen Med. 2015;9:E84-97 pubmed publisher
  184. Roubelakis M, Tsaknakis G, Pappa K, Anagnou N, Watt S. Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS ONE. 2013;8:e54747 pubmed publisher
  185. Suetta C, Frandsen U, Jensen L, Jensen M, Jespersen J, Hvid L, et al. Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy. PLoS ONE. 2012;7:e51238 pubmed publisher
  186. Criswell T, Corona B, Wang Z, Zhou Y, Niu G, Xu Y, et al. The role of endothelial cells in myofiber differentiation and the vascularization and innervation of bioengineered muscle tissue in vivo. Biomaterials. 2013;34:140-9 pubmed publisher
  187. Büttner M, Kufer V, Brunner K, Hartmann A, Amann K, Agaimy A. Benign mesenchymal tumours and tumour-like lesions in end-stage renal disease. Histopathology. 2013;62:229-36 pubmed publisher
  188. Kim S, Moon G, Cho Y, Kang H, Hyung N, Kim D, et al. Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease. PLoS ONE. 2012;7:e37036 pubmed publisher
  189. Sölder E, Böckle B, Nguyen V, Fürhapter C, Obexer P, Erdel M, et al. Isolation and characterization of CD133+CD34+VEGFR-2+CD45- fetal endothelial cells from human term placenta. Microvasc Res. 2012;84:65-73 pubmed publisher
  190. Lee C, Hwang I, Park C, Lee H, Park D, Kang S, et al. Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina. Biomarkers. 2012;17:209-15 pubmed publisher
  191. Yuan S, Chen R, Shen W, Chen H, Zhou X. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region. Pediatr Dev Pathol. 2012;15:5-12 pubmed publisher
  192. Sellheyer K, Krahl D. Spatiotemporal expression pattern of neuroepithelial stem cell marker nestin suggests a role in dermal homeostasis, neovasculogenesis, and tumor stroma development: a study on embryonic and adult human skin. J Am Acad Dermatol. 2010;63:93-113 pubmed publisher
  193. Shirasaki H, Kanaizumi E, Himi T. Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm. 2009;2009:102406 pubmed publisher